You are here

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Checkpoint Blockade Therapy
498 ES015, a first-in-class NKG2A and NKG2C dual-targeting antibody, demonstrated potent anti-tumor immune response

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023282029
Dec 202387010
Jan 20243404
Feb 20242002
Mar 20244605
Apr 20241802
May 20245408
Jun 20242606
Jul 20245608
Aug 20242601
Sep 20245605
Oct 20243407
Nov 202488014
Dec 202452010
Jan 202566011
Feb 2025803
Mar 2025007
Apr 2025004
May 2025004
Jun 2025005
Total9530145